Treatment for Neonatal Abstinence Syndrome

ONLINECMECNENAS
Treatment for Neonatal Abstinence Syndrome Banner

Instructions

Date & Location
Sunday, April 1, 2018, 12:00 AM - Tuesday, December 31, 2019, 11:59 PM, Online

Target Audience
Specialties - Maternal-Fetal Medicine/Perinatal, Neonatology

Credits
AMA PRA Category 1 Credits™ (1.25 hours), ANCC Nursing Contact Hour(s) (1.25 hours), Non-Physician (Attendance) (1.25 hours)

Overview
There is currently an epidemic of Neonatal Abstinence Syndrome (NAS) and there are no robust data regarding optimal treatment. Clinicians need to understand the data available about best practices for treatment, including following the AAP clinical highlights. Clinicians also need to understand both non-pharmacologic and pharmacologic methods to treat NAS.

ACCME Objectives
  1. Clinicians will implement at least one unit-based change to improve care in the treatment of NAS.

ANCC Learning Outcomes
  1. Clinicians will implement at least one unit-based change to improve care in the treatment of NAS.

Accreditation

The MEDNAX Center for Research, Education, Quality and Safety is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The MEDNAX Center for Research, Education, Quality and Safety designates this Enduring Material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The MEDNAX Center for Research, Education, Quality and Safety is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. (#PO258)

The MEDNAX Center for Research, Education, Quality and Safety designates this Enduring Material for a maximum of 1.25 nursing contact hour(s). Participants should only claim credit commensurate with the extent of their participation in the activity.